Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

pembrolizumab 77Cyclophosphamide 50Cisplatin 47Nivolumab 37Paclitaxel 34Radiotherapy 33Carboplatin 32Gemcitabine 30Docetaxel 27Dexamethasone 24atezolizumab 23Doxorubicin 21Bevacizumab 21Etoposide 20Blood Specimen Collection 20Magnetic Resonance Spectroscopy 19Vincristine 18Radiosurgery 18Leucovorin 18Lenalidomide 18Fluorouracil 18fludarabine 17Rituximab 17Surveys and Questionnaires 16Oxaliplatin 16Ipilimumab 16Cytarabine 16palbociclib 15Radiation 15Letrozole 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Outcome Assessment, Health Care × 90 days × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡